ArticleFrontiers in cell and developmental biology2024

Efficacy and safety of pegylated liposomal doxorubicin and epirubicin as neoadjuvant chemotherapy for breast cancer.

Yuanyuan Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.